Disseminated bartonellosis in a child with steroid-dependent nephrotic syndrome receiving mycophenolate mofetil monotherapy - 30/09/21
Highlights |
• | Mycophenolate mofetil is considered as a safe treatment with low infectious risk. |
• | Disseminated bartonellosis may occur under mycophenolate mofetil monotherapy. |
• | Patients receiving mycophenolate mofetil should be cautious with cat contacts. |
Abstract |
Cat scratch disease, usually a benign infectious disease, may develop as multisystem disease with multiorgan involvement, particularly in immunocompromised patients. We report on a patient who developed disseminated bartonellosis while receiving mycophenolate mofetil monotherapy treating steroid-dependent nephrotic syndrome, highlighting that severe infection can be observed in those patients. Therefore, this category of patients should be cautious when having contact with kittens and receives proper prevention advice.
El texto completo de este artículo está disponible en PDF.Keywords : Bartonellosis, Mycophenolate mofetil, Steroid-dependent nephrotic syndrome
Esquema
Vol 17 - N° 6
P. 463-465 - octobre 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?